UNSPSC 51162308: Acetaminophen/caffeine/phenylpropanolamine/salicylamide

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE599. This VA Drug Class (RE599) classifies this compound as belonging to the group COLD REMEDIES, OTHER.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51162308 Acetaminophen/caffeine/phenylpropanolamine/salicylamide is a Commodity code that in practice covers a much broader range of pharmaceutical and over-the-counter products than its narrow name suggests. State and local governments use this code to procure generic multi-source pharmaceuticals, OTC medications, and related health-supply products for distribution through community health facilities, county health departments, and state agency networks. Recent solicitations show purchasing concentrated on bulk pharmaceutical supply contracts and specialized health-response products rather than the specific combination drug named in the code itself. Issuing bodies include county health departments, state procurement offices administering multi-jurisdictional cooperative purchasing agreements, and health-focused special-purpose districts. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, represents a significant repeat buyer, aggregating demand across multiple states and local government members.

Recent activity spans at least Florida and Minnesota, with MMCAP's multi-state cooperative extending into Oregon and other participating jurisdictions. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with a response deadline of July 26, 2023, requiring quarterly deliveries to the Seminole County Community Health Building in Sanford and electronic bid submission through the county's e-Procurement Portal. MMCAP released RFP S1070000015802 on January 20, 2026, with responses due March 26, 2026, to establish multiple contracts for generic multi-source pharmaceuticals and OTC products for distribution through state and local government facilities; the RFP requires vendors to work through three authorized wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health, and Morris & Dickson), maintain cGMP and DSCSA compliance, and submit pricing and product data in CSV format, with contract awards effective July 1, 2026.